These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. [Role of beta-lactamase inhibitors in the etiotropic therapy of infectious diseases]. Orlov VA; Sarsenbaeva DI Antibiot Khimioter; 1993; 38(4-5):63-70. PubMed ID: 8031200 [No Abstract] [Full Text] [Related]
53. [Combined preparations of semisynthetic penicillins and beta-lactamase inhibitors: a method for overcoming resistance and the broadening of therapeutic possibilities]. Antibiot Khimioter; 2000; 45(3):3. PubMed ID: 10768056 [No Abstract] [Full Text] [Related]
54. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. Akova M Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853 [TBL] [Abstract][Full Text] [Related]
55. Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience. Tiberi S; D'Ambrosio L; De Lorenzo S; Viggiani P; Centis R; Sotgiu G; Alffenaar JW; Migliori GB Eur Respir J; 2016 Jan; 47(1):333-6. PubMed ID: 26585427 [No Abstract] [Full Text] [Related]